SEC Filing Summary: Bioptix, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bioptix, Inc. (not Riot Platforms, Inc.) on July 3, 2017, reporting events occurring on June 30, 2017. The filing addresses Item 5.02 regarding the appointment of certain officers and compensatory arrangements.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on executive compensation terms.
- Executive Base Salary: $272,005 annually for the Chief Financial Officer (Jeffrey McGonegal).
- Lump-Sum Payment: $50,000 paid to the CFO in exchange for waiving rights to 67,172 outstanding stock options.
- Restricted Stock Units (RSUs): 20,000 RSUs awarded to the CFO, vesting on the Employment Termination Date.
- Option Termination Provision: A computed payment mechanism exists to terminate 21,000 outstanding stock options based on specific share price achievements or notice.
Material Changes
Effective June 30, 2017, the Board of Directors approved a new Retention Agreement with Jeffrey McGonegal, CFO and Principal Accounting Officer. This agreement supersedes his previous employment contract and extends his service term until April 30, 2018, unless terminated sooner.
Outlook, Risks, and Contingencies
The filing outlines specific contingencies regarding the CFO's compensation:
- Termination Protection: If employment is terminated without Cause or due to disability, the CFO is entitled to receive his base salary through April 30, 2018.
- Equity Adjustments: Future payments are contingent upon the achievement of a specified common share closing price or the CFO providing notice to terminate specific stock options.
Investor Verification Checklist
- Verify the full text of the Retention Agreement filed as Exhibit 10.1 for complete definitions of "Cause," "Disability," and the "Employment Termination Date."
- Confirm the current status of the 67,172 waived stock options and the 21,000 options subject to the computed payment provision.
- Review the company's cash position to assess the impact of the $50,000 lump-sum payment and potential future option termination payments.
- Note the discrepancy between the requested company name (Riot Platforms) and the actual registrant (Bioptix, Inc.) in the source text.